These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25236906)

  • 1. Surrogacy marker paradox measures in meta-analytic settings.
    Elliott MR; Conlon AS; Li Y; Kaciroti N; Taylor JM
    Biostatistics; 2015 Apr; 16(2):400-12. PubMed ID: 25236906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accommodating missingness when assessing surrogacy via principal stratification.
    Elliott MR; Li Y; Taylor JM
    Clin Trials; 2013; 10(3):363-77. PubMed ID: 23553326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surrogate markers for time-varying treatments and outcomes.
    Hsu JY; Kennedy EH; Roy JA; Stephens-Shields AJ; Small DS; Joffe MM
    Clin Trials; 2015 Aug; 12(4):309-16. PubMed ID: 25948621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of surrogate endpoints in cancer clinical trials via principal stratification with an application to a prostate cancer trial.
    Tanaka S; Matsuyama Y; Ohashi Y
    Stat Med; 2017 Aug; 36(19):2963-2977. PubMed ID: 28485043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the relationship between the causal-inference and meta-analytic paradigms for the evaluation of surrogate endpoints.
    Van der Elst W; Molenberghs G; Alonso A
    Stat Med; 2016 Apr; 35(8):1281-98. PubMed ID: 26612787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive cluster level surrogacy in the presence of interference.
    Gabriel EE; Follmann DA
    Biostatistics; 2020 Apr; 21(2):e33-e46. PubMed ID: 30247535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Links between causal effects and causal association for surrogacy evaluation in a gaussian setting.
    Conlon A; Taylor J; Li Y; Diaz-Ordaz K; Elliott M
    Stat Med; 2017 Nov; 36(27):4243-4265. PubMed ID: 28786131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surrogate measures and consistent surrogates.
    Vanderweele TJ
    Biometrics; 2013 Sep; 69(3):561-9. PubMed ID: 24073861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the relationship between the causal-inference and meta-analytic paradigms for the validation of surrogate endpoints.
    Alonso A; Van der Elst W; Molenberghs G; Buyse M; Burzykowski T
    Biometrics; 2015 Mar; 71(1):15-24. PubMed ID: 25274284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A reflection on the causal interpretation of individual-level surrogacy.
    Alonso A; Van Der Elst W; Molenberghs G; Florez AJ
    J Biopharm Stat; 2019; 29(3):529-540. PubMed ID: 30773114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermediate markers as surrogate endpoints in cancer research.
    Schatzkin A
    Hematol Oncol Clin North Am; 2000 Aug; 14(4):887-905. PubMed ID: 10949779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the relationship between association and surrogacy when both the surrogate and true endpoint are binary outcomes.
    Meyvisch P; Alonso A; Van der Elst W; Molenberghs G
    Stat Med; 2020 Nov; 39(26):3867-3878. PubMed ID: 32875590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the value of a censored surrogate outcome.
    Parast L; Tian L; Cai T
    Lifetime Data Anal; 2020 Apr; 26(2):245-265. PubMed ID: 30980316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The individual-level surrogate threshold effect in a causal-inference setting with normally distributed endpoints.
    Van der Elst W; Abad AA; Coppenolle H; Meyvisch P; Molenberghs G
    Pharm Stat; 2021 Nov; 20(6):1216-1231. PubMed ID: 34018666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A maximum entropy approach for the evaluation of surrogate endpoints based on causal inference.
    Alonso A; Van der Elst W; Molenberghs G
    Stat Med; 2018 Dec; 37(29):4525-4538. PubMed ID: 30141219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surrogacy assessment using principal stratification when surrogate and outcome measures are multivariate normal.
    Conlon AS; Taylor JM; Elliott MR
    Biostatistics; 2014 Apr; 15(2):266-83. PubMed ID: 24285772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An information-theoretic approach for the evaluation of surrogate endpoints based on causal inference.
    Alonso A; Van der Elst W; Molenberghs G; Buyse M; Burzykowski T
    Biometrics; 2016 Sep; 72(3):669-77. PubMed ID: 26864244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surrogacy assessment using principal stratification with multivariate normal and Gaussian copula models.
    Taylor JM; Conlon AS; Elliott MR
    Clin Trials; 2015 Aug; 12(4):317-22. PubMed ID: 25490988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis for the evaluation of potential surrogate markers.
    Daniels MJ; Hughes MD
    Stat Med; 1997 Sep; 16(17):1965-82. PubMed ID: 9304767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.